Category page
Genomics companies in Europe — biotech directory
European genomics companies cover next-generation sequencing services (NGS), single-cell platforms, population genomics, gene editing (CRISPR-based platforms), molecular diagnostics, and bioinformatics infrastructure. Anchors include Atrandi Biosciences (Vilnius, single-cell), CasZyme (Vilnius, CRISPR-Cas IP), Asper Biogene (Tartu, clinical genetics), Solis BioDyne (Tartu, molecular tools), Estonian Genome Project, plus larger operators like Qiagen, Illumina Cambridge, and the Welcome Sanger Institute ecosystem.
Where does this category cluster most clearly?
Genomics is currently most visible through Lithuania (3), Finland (1), Estonia (1), and Poland (1). Top cities: Vilnius, Lithuania (2), Espoo, Finland (1), Kaunas, Lithuania (1), and Tartu, Estonia (1). Most legible records: CeGaT GmbH, Genomed, Genomika, and Saidė Genomics.
Which standards and public evidence are already visible?
Not yet available.. Latest review: 24 April 2026. Review cycle: April 2026.
Why this category matters
This page brings companies and infrastructure records into one practical category view so users can compare markets and cities more quickly.
By country
Genomics by country
Jump into a country-specific page filtered to this category only.
Full list
Genomics records
7 category records currently match the active filter.
Current review cycle
CeGaT GmbH
TuebingenGermanyGenomics
Tuebingen clinical NGS genomic diagnostics operator running diagnostic panels, whole-exome and whole-genome sequencing, and research sequencing services under DIN EN ISO 15189 and DIN EN ISO 17025 accreditations, with CAP and CLIA recognition.
- Lead
- Saskia BiskupManaging Director and Co-Founder
- Scale
- Clinical and research genomic service delivery
Current review cycle
Genomed
WarsawPolandGenomics
Warsaw genomics and diagnostics company providing DNA and RNA sequencing, genetic testing, and molecular diagnostics from a long-running Polish genomics platform.
- Lead
- Anna Boguszewska-ChachulskaChief Executive Officer
- Scale
- Diagnostics and genomics services platform
Current review cycle
Genomika
KaunasLithuaniaGenomics
Kaunas applied-biotechnology research company providing genomics, bioinformatics, wet-lab execution, experimental design, and DNA-storage related development services.
- Lead
- Mantas SimutisChief Executive Officer
- Scale
- Applied genomics and biotechnology services platform
Current review cycle
Saidė Genomics
VilniusLithuaniaGenomics
Vilnius molecular-diagnostics and genomics laboratory delivering NIPT, pharmacogenomics, cancer testing, sequencing services, and personalized research workflows from Lithuania.
- Lead
- Arūnas LeipusDirector
- Scale
- Clinical genomics and sequencing platform
Current review cycle
Asper Biogene
TartuEstoniaGenomics
Tartu genetic-testing laboratory offering disease-specific DNA panels, exome and genome services, and accredited diagnostic workflows from Estonia.
- Lead
- Hardi TammChief Executive Officer
- Scale
- Clinical genetic testing and sequencing services
Current review cycle
Blueprint Genetics
EspooFinlandGenomics
Espoo genetic-testing and genomic-diagnostics laboratory delivering rare-disease panels, exome and genome sequencing, and accredited clinical interpretation from Finland.
- Lead
- Juhana RauramoVice President and General Manager; Managing Director
- Scale
- Global clinical genetic testing from Espoo
Current review cycle
CasZyme
VilniusLithuaniaGenomics
Vilnius CRISPR enzyme-discovery and genome-editing company building programmable nuclease platforms, custom research programs, and translational partnerships from its Lithuanian R&D base.
- Lead
- Dr. Giedrius GasiūnasChief Executive Officer and Co-Founder
- Scale
- Molecular
FAQ
Frequently asked questions
- What is a genomics company?
- Companies developing or providing genomic and sequencing technologies — DNA/RNA sequencing platforms, single-cell analysis, gene editing tools, population genomics infrastructure, bioinformatics services, or clinical molecular diagnostics. Many overlap with diagnostics; the genomics filter is for organizations whose primary business is genome-scale analysis.
- Which European countries lead in genomics?
- Estonia leads per capita (Estonian Genome Project, Asper Biogene, Tartu cluster). Lithuania has a strong CRISPR/Cas IP base (CasZyme, Atrandi). Germany hosts deep industrial genomics (Qiagen, CeGaT). The Nordics carry strong population genomics and clinical sequencing programs (Sweden, Denmark, Iceland).
- What is the difference between genomics and diagnostics?
- Diagnostics is broader — any test that identifies disease or biological state (immunoassays, PCR, biochemistry, imaging, etc.). Genomics specifically uses DNA/RNA-level analysis. Many genomics companies sell their tests as IVDs (regulated diagnostics under EU IVDR), so the categories overlap. Use the genomics filter when sequencing or genome-scale analysis is the core capability; use diagnostics when broader testing portfolio is the focus.
- How are genomics companies verified in this directory?
- Every profile is hand-reviewed: leadership confirmed by primary source, physical site address sourced from official disclosures, capability claims backed by published patents, certifications (ISO 13485 where applicable), or peer-reviewed publications, and a registry note explaining current operating context.
Next step
Read the category, then move into cities and countries.
Use city pages for local concentration, country pages for market context, and the methodology page when you want to understand how records are reviewed.